Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263
View Patent ↗MicroRNAs (miRNAs) that sensitize cancer cells to Bcl-2 family protein inhibitors are identified and described. Oligonucleotide panels, arrays and methods using the sensitizing miRNAs are also disclosed.
1. A panel of primers or probes for determining an miRNA profile in a biological sample, the panel comprising:
at least two miRNA primers or probes, each primer or probe capable of selectively binding one of at least two human miRNA selected from SEQ ID NOS: 1-19; and
a solid support, wherein the primers or probes are probes immobilized on the solid support to form an array.
2. A panel of primers or probes according to claim 1 , wherein the solid support comprises one or more components selected from the group consisting of: a membrane, a chip, a disk, a strip, a filter, a microsphere, a slide, a multiwell plate, a bead, or an optical fiber.
3. A kit useful for assaying miRNA expression levels in a biological sample of a subject, the kit comprising: a) a panel of two or more oligonucleotide primers or probes, each primer or probe capable of selectively binding a human miRNA selected from the group consisting of: SEQ ID NOS: 1-19; b) one or more reagents for amplifying the miRNA present in the biological sample using the primers or probes; and c) instructions for quantifying expression levels of the miRNA in the biological sample and evaluating the sensitivity of the subject to treatment with a Bcl-2 family protein inhibitor based on the expression levels of the miRNA.
4. The kit of claim 3 , wherein the one or more miRNAs are selected from the group consisting of SEQ ID NOS: 1-12.
5. The kit of claim 3 , wherein the one or more miRNAs are selected from the group consisting of SEQ ID NOS: 1-10.
6. The kit of claim 3 further comprising a solid support, wherein the probes or primers comprise probes immobilized on the solid support.
7. The kit of claim 6 , wherein the solid support comprises one or more components selected from the group consisting of: a membrane, a chip, a disk, a strip, a filter, a microsphere, a slide, a multiwell plate, a bead, or an optical fiber.
8. The kit of claim 3 , wherein the biological sample is selected from the group consisting of: a cell lysate, a cell culture, a cell line, a tissue, a biological fluid, a blood sample, a serum sample, a plasma sample, a urine sample, and a skin sample.
9. The kit of claim 3 , wherein the one or more reagents comprise one or more miRNA hybridization or amplification reagents for any two or more of the miRNAs.